IFRX
InflaRx N.V.
NASDAQ · Healthcare · Biotechnology · DE
$2.22
−0.45%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.07
- Revenue estimate
- $6.1K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.11
- EPS estimate
- -$0.07
- Revenue actual
- —
- Revenue estimate
- $6.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -3.1%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026